Advances in immunostains used in Mohs surgery

Journal of Drugs in Dermatology

Volumn 9, Issue 7, 2010, Pages 760-763

  Stranahan, Donald R ^a   Cherpelis, Basil S ^a   Fenske, Neil Alan ^a   Glass, L Frank ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN AE1; CYTOKERATIN AE3; CYTOKERATIN ANTIBODY; MELAN A; MELANOMA ANTIGEN; MELANOMA ANTIGEN 5; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MONOCLONAL ANTIBODY HMB 45; PROTEIN S 100; UNCLASSIFIED DRUG; KERATIN;

BASAL CELL CARCINOMA; CANCER DIAGNOSIS; CELL COUNT; CELL DENSITY; CELL NUCLEUS; CELL SIZE; CHEMOSURGERY; CLINICAL PROTOCOL; COST EFFECTIVENESS ANALYSIS; FROZEN SECTION; HUMAN; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MEDICARE; MELANOCYTE; MELANOMA; REVIEW; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; TIME; ARTICLE; CHEMISTRY; METHODOLOGY; SKIN TUMOR;

HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MELANOMA; MOHS SURGERY; SKIN NEOPLASMS;

EID: 77955905945     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Robinson JK, Gottschalk R. Immunofluorescent and immunoperoxidase staining of antibodies to fibrous keratin. Arch Dermatol. 1984;120(2);199-203.
2. Mondragon RM, Barrett TL. Current concepts: The use of immunoperoxidase techniques in Mohs micrographic surgery. J Am Acad Dermatol. 2000;43(1):66-71. (Pubitemid 30439715)
3. Salmon RM. The use of monoclonal antibody stains in Mohs micrographic surgery. Aust J Dermatol. 1997:38(1);44-45. (Pubitemid 27166525)
4. Thosani MK, Marghoob A, Chen CS. Current progress of immunostains in Mohs micrographic surgery: A review. Dermatol Surg. 2008;34(12):1621-1636.
5. Stranahan DR, Cherpelis BS, Glass LF, et al. Immunohistochemical stains in Mohs surgery: A review. Dermatol Surg. In press.
6. Dawn ME, Dawn AG, Miller SJ. Mohs surgery for the treatment of melanoma in situ: a review. Dermatol Surg. 2007;33(4):395-402. (Pubitemid 46570109)
7. Zalla MJ, Lim KK, DiCaudo DJ, et al. Mohs micrographic excision of melanoma using immunostains. Dermatol Surg. 2000;26(8):771- 784.
8. Griego RD and Zitelli JA. Mohs micrographic surgery using HMB-45 for a recurrent acral melanoma. Dermatol Surg. 1998;24(9):1003- 1006.
9. Gross EA, Andersen WK, Rogers GS. Mohs micrographic excision of lentigo maligna using Mel-5 for margin control. Arch Dermatol. 1999;135(1):15-17. (Pubitemid 29069511)
10. Bhardwaj SS, Tope WD, Lee PK. Mohs micrographic surgery forlentigo maligna and lentigo maligna melanoma using Mel-5 immunostaining: University of Minnesota experience. Dermatol Surg. 2006;32(5):690-696. (Pubitemid 43742533)
11. Albertini, JG, Elston DM, Libow LF, et al. Mohs micrographic 11. surgery for melanoma: A case series, a comparative study of immunostains, an informative case report, and a unique mapping technique. Dermatol Surg. 2002;28(8):656-665. (Pubitemid 34913271)
12. Kelley LC and Starkus LS. Immunohistochemical staining of lentigo maligna during Mohs micrographic surgery using MART-1. J Am Acad Dermatol. 2002;46(1):78-84. (Pubitemid 34073482)
13. Geisse JK. Re: Questionable utility of melan-A/Mart-1 immunoperoxidase staining while doing Mohs surgery for melanoma. Dermatol Surg. 2005;31(4):495. (Pubitemid 40489322)
14. El Shabrawi-Caelen L, Kerl H, and Cerroni L. Melan-A: Not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actininc keratosis. Am J Dermatopathol. 2004;26(5):364-366.
15. Hendi A, Brodland DG, Zitelli JA. Melanocytes in long-standing sun-exposed skin: quantitative analysis using the MART-1 immunostain. Arch Dermatol. 2006;142(7):871-876. (Pubitemid 44079787)
16. Cherpelis BS, Moore R, Ladd S, et al. Comparison of MART-1 frozen sections to permanent sections using a rapid 19-minute protocol. Dermatol Surg. 2009;35(2):207-213.
17. Kimyai-Asadi A, Ayala GB, Goldberg LH, et al. The 20-minute rapid MART-1 immunostain for malignant melanoma frozen sections. Dermatol Surg. 2008;34(4):498-500. (Pubitemid 351442694)
18. Clark GS, Pappas-Politis EC, Cherpelis BS, et al. Surgical management of melanoma in situ on chronically sun-damaged skin. Cancer Control. 2008;15(3):216-224.
19. Bricca GM, Brodland DG, Zitelli JA. Immunostaining melanoma frozen sections: The one-hour protocol. Dermatol Surg. 2004;30(3):403-408. (Pubitemid 38524161)
20. Davis DA, Kurtz K, Robinson RA. Ultrarapid staining for cutaneous melanomas: Study and protocol. Dermatol Surg. 2005;31(7 Pt 1):754-756.
21. Ohsie SJ, Sarantopoulos GP, Cochrane AJ, Binder SW. Immunohistochemical characteristics of melanoma. J Cut Pathol. 2008;35(5):433-444. (Pubitemid 351519417)
22. King R, Weilbaecher KN, McGill G, et al. Microphthalmia transcription factor, a sensitive and specific melanocyte marker for melanoma diagnosis. Am J Pathol. 1999;155(3):731-738. (Pubitemid 29426819)
23. Calder K, Higgins H, Clark G, et al. Rapid frozen tissue immunostaining of melanocytes by microophthalmic transcription factor. Abstract. J Cutan Pathol. 2009;36(1):180.
24. Jiminez, FJ, Grichnik, JM, Buchanan, MD, et al. Immunohistochemical techniques in Mohs micrographic surgery: Their potential use in the detection of neoplastic cells masked by inflammation. J Am Acad Dermatol. 1995;32(1):89-94.
25. Smeets, NW, Stavast-Kooy AJ, Krekels, GA, et al. Adjuvant cytokeratin staining in Mohs micrographic surgery for basal cell carcinoma. Dermatol Surg. 2003;29(4):375-377. (Pubitemid 36417451)
26. Cherpelis BS, Turner L, Ladd S, et al. Innovative 19 minute rapid cytokeratin immunostaining of nonmelanoma skin cancer in Mohsmicrographic surgery. Dermatol Surg. 2009;35(7):1-7.
27. Zachary CB, Rest EB, Furlong SW, et al. Rapid cytokeratin stains enhance the sensitivity of Mohs micrographic surgery for squamous cell carcinoma. J Dermatol Surg Oncol. 1994;20(8):530-535. (Pubitemid 24260539)